Back to top

Image: Bigstock

Vishay Intertechnology (VSH) Surpasses Q4 Earnings & Revenues

Read MoreHide Full Article

Vishay Intertechnology, Inc. (VSH - Free Report) delivered fourth-quarter 2018 adjusted earnings of 58 cents per share, which surpassed the Zacks Consensus Estimate by 7 cents. The figure surged 56.7% year over year but declined 3.3% sequentially.

Revenues increased 15.2% on a year-over-year basis but decreased 0.6% on a sequential basis to $775.9 million. Notably, the figure came ahead of the Zacks Consensus Estimate of $761 million.

The company’s strong performance in automotive and industrial markets drove year-over-year growth. Moreover, strengthening manufacturing capacities of the company contributed well.

Further, increasing demand in almost all markets and solid momentum across all regions was a major positive.

Additionally, the book-to-bill ratio of the company was 0.94 at the end of the reported quarter.

Although supply has started to catch up with demand, supply shortage still remains a major concern in the healthy demand market. Further, imposition of U.S. tariffs is negatively impacting the company’s performance in the Chinese industrial market.

Notably, shares of Vishay Intertechnology have returned 20.6% over a year, underperforming the industry’s rally of 43.7%.



Product Segments in Detail

Resistors & Inductors: This product segment generated $262 million revenues (33.8% of total revenues), up 23% year over year. The product’s robust performance across automotive, industrial, medical and military end markets continued to accelerate revenues from this product line. Moreover, positive contributions from the acquisition of UltraSource drove the sales of this product. The book-to-bill ratio for this product is at 0.94 in the reported quarter.

MOSFET: This product line generated $139 million revenues (18% of total revenues), advancing 15% year over year. The book-to-bill ratio for this product stood at 1.08 at the end of the reported quarter. The company witnessed sustained performance of this product line in the automotive end market. Further, robust MOSFET transistors continued to aid the company’s market position. Additionally, expanding internal and foundry capacities for MOSFETs are tailwinds.

Capacitors: The company generated $131 million revenues (16.9% of total revenues) from the sale of this product line, up 26% year over year. Continued solid momentum with this product line in America and Europe remained positive throughout the quarter under review. Further, growing opportunities for capacitors in China in the areas of power transmission and electro cars are tailwinds. The book-to-bill ratio for this product stood at 1.02 in the reported quarter.

Diodes: The company yielded $177 million revenues (22.8% of total revenues) from this product segment, surging 12% from the year-ago quarter. The strong momentum of this product in the automotive and industrial sector continued to accelerate its sales. The book-to-bill ratio for this product stood at 0.83 during the quarter under review.

Optoelectronics: This product line generated $66 million revenues (8.5% of total revenues) during the reported quarter. The figure was down 4.5% from the year-ago quarter. The book-to-bill ratio for this product stood at 0.75 during the fourth quarter. Weakness in the Chinese consumer market remained an overhang for these products.

Vishay Intertechnology, Inc. Price, Consensus and EPS Surprise

 

Vishay Intertechnology, Inc. Price, Consensus and EPS Surprise | Vishay Intertechnology, Inc. Quote

Operating Details

In fourth-quarter 2018, gross margin came in at 28.3%, expanding 200 basis points (bps) on a year-over-year basis.

Selling, general and administrative expenses were $100.02 million, increasing 4.9% year over year. However, as a percentage of total revenues, the figure contracted 120 bps from the year-ago quarter.

Per the company, operating margin came in at 15.4%, expanding 410 bps from the year-ago quarter. Adjusted EBITDA margin was 20.1%, expanding 240 bps year over year.

Balance Sheet & Cash Flows

As of Dec 31, 2018, cash and cash equivalents were $686.03 million, declining from $928.1 million as of Sep 29, 2018. Short-term investments were $78.3 million, down from $135 million in the previous quarter. Inventories were $479.7 million, declining from $500.3 million in the previous quarter.

In the fourth quarter, the company generated $150 million of cash from operations, up from $70.7 million in the previous quarter.

The company’s free cash flow in the fourth quarter came in $93.2 million, significantly up from $21.05 million in the third quarter.

Guidance

For first-quarter 2019, Vishay Intertechnology expects total revenues to be in the range of $730 million to $770 million. The Zacks Consensus Estimate for revenues is pegged at $743 million.

Further, the company anticipates gross margin to lie between the range of 28% and 29%.

Zacks Rank and Stocks to Consider

Vishay Intertechnology carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader technology sector are TripAdvisor (TRIP - Free Report) , Upland Software (UPLD - Free Report) and RingCentral (RNG - Free Report) . While TripAdvisor sports a Zacks Rank #1 (Strong Buy), Upland Software and RingCentral carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term earnings growth rate for TripAdvisor, Upland Software and RingCentral is currently pegged at 14.05%, 20% and 35%, respectively.

Zacks' Top 10 Stocks for 2019

In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?

From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.

This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.

See Stocks Today >>

Published in